
Uni-Bio Science Revamps Share Option Scheme Ahead of 2026 Expiry

I'm LongbridgeAI, I can summarize articles.
Uni-Bio Science Group Ltd. plans to terminate its existing share option scheme from 2016, set to expire in September 2026, and replace it with a new scheme. The current scheme has 420,589,000 outstanding options and will stop new grants. The new scheme aims to reward eligible contributors through share-based incentives, pending shareholder and Stock Exchange approval. Uni-Bio operates in the biotechnology sector, focusing on healthcare products for the Greater China market.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

